Effect of interferon-α on the expression of tumour necrosis factor-α by metastatic malignant melanoma in vivo

Melanoma Research

Volumn 7, Issue 2, 1997, Pages 139-145

  Hakansson A ^a   Gustafsson, B ^a   Krysander, L ^a   Bergenwald, C ^a   Sander, B ^a   Hakansson L ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

expression; interferon , malignant melanoma; metastases; treatment; tumour necrosis factor

Indexed keywords

ALPHA INTERFERON; CYCLOPHOSPHAMIDE; INDOMETACIN; MESSENGER RNA; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MALE; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; STAINING; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR REGRESSION;

EID: 0031004787     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199704000-00008     Document Type: Article

References (28)

1. Carswell EA, Old LJ, Kassel RL, et al. An endotoxin induced serum factor that causes necrosis of tumours. Proc Natl Acad Sci 1975; 72: 3666-3670.
2. Sidhu RS, Bollon P. Tumour necrosis factor activities and cancer therapy - a perspective. Pharmacol Ther 1993; 57: 79-128.
3. Vassalli P. The pathophysiology of tumour necrosis factors. Annu Rev Immunol 1992; 10: 411-452.
4. Balkwill F. Tumour necrosis factor and cancer. Prog Growth Factor Res 1992; 4: 121-137.
5. Remick DG, Kunkel SL. Pathophysiologic alterations induced by tumour necrosis factor. Int Rev Exp Pathol 1993; 34B: 7-25.
6. Spriggs DR, Imamura K, Rodriguez C, et al. Tumour necrosis factor expression in human epithelial tumour cell lines. J Clin Invest 1988; 81: 455-460.
7. Naylor MS, Malik STA, Stamp GWH, et al. In situ detection of tumour necrosis factor in human ovarian cancer specimens. Eur J Cancer 1990; 26: 1027-1030.
8. Takeyama HWN, O'Hara C, Arthur K, et al. Tumour necrosis factor expression by human ovarian carcinoma in vivo. Cancer Res 1991; 51: 4476-4480.
9. Filer RS, Song JC, Char DH, et al. Uveal melanoma cytokines. Kiln Monatsbl Augenheilkd 1993; 202: 174-179.
10. Xerri L, Birg F, Guigou V, et al. In situ expression of the IL-1β and TNF-α genes by Reed-Sternberg cells in Hodgkin's disease. Int J Cancer 1992; 50: 689-693.
11. Ahmed AA, Nordlind K, Hedblad M, et al. Interleukin (IL)-1 alpha and beta, IL-6, and tumour necrosis factor-alpha-like immunoreactivities in human common and dysplastic nevocellular nevi and malignant melanoma. Am J Dermatopathol 1995; 17: 222-229.
12. Sander B, Boeryd B. Tumour necrosis factor-alpha expression in human primary malignant melanoma and its relationship to tumour infiltration by CD3+ cells. Int J Cancer 1996; 66: 42-47.
13. Lattime EC, Mastrangelo MJ, Bagasra O, et al. Expression of cytokine mRNA in human melanoma tissues. Cancer Immunol Immunother 1995; 41:151-156.
14. Pennica D, Nedwin GE, Hayflick JS, et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984; 312: 724-729.
15. Westermark GT, Christmanson L, Terenghi G, et al. Islet amyloid polypeptide: demonstration of mRNA in human pancreatic islets by in situ hybridization in islets with and without amyloid deposits. Diabetologia 1993; 36: 323-328.
16. McGovern VJ. Spontaneous regression of melanoma. Pathology 1975; 7: 91-99.
17. Kang SBRL, Mihm MC, Sober AJ. Histologic regression in malignant melanoma: an interobserver concordance study. J Cutan Pathol 1993; 20: 126-129.
18. Sondergaard K, Hou-Jensen K. Partial regression in thin primary cutaneous malignant melanomas clinical stage I. Virchows Arch A Pathol Anat Histopathol 1985; 408: 241-247.
19. Ronan SG, Eng AM, Briele HA, et al. Thin malignant melanomas with regression and metastases. Arch Dermatol 1987; 123: 1326-1330.
20. Bennicelli JL, Guerry D. Production of multiple cytokines by cultured human melanomas. Exp Dermatol 1993; 2: 186-190.
21. Lugassy C, Escande J-P. Immunolocation of TNF-alpha/ Cachectin in human melanoma cells: Studies on co-cultivated malignant melanoma. J Invest Dermatol 1991; 96: 238-242.
22. Rubin BY, Anderson SL, Sullivan SA, et al. Non-hematopoietic cells selected for resistance to tumour necrosis factor produce tumour necrosis factor. J Exp Med 1986; 164: 1350-1355.
23. Spriggs D, Imamura K, Rodriguez C, et al. Induction of tumour necrosis factor expression and resistance in a human breast tumour cell line. Proc Natl Acad Sci 1987; 84: 6563-6566.
24. Malik ST, Naylor MS, East N, et al. Cells secreting TNF show enhanced metastasis in nude mice. Eur J Cancer 1990; 26: 1031-1034.
25. Gifford GE, Lohmann-Matthes M-L. Gamma-interferon priming of mouse and human macrophage for induction of tumour necrosis factor production by bacterial lipopolysaccharide. J Natl Cancer Inst 1987; 78: 121-124.
26. Bethea JR, Yup Chung I, Sparacio SM, et al. Interleukin 1-beta induction of tumour necrosis factor alpha gene expression in human astroglioma cells. J Neuroimmunol 1992; 36: 179-191.
27. Kasid ADEP, Stovroff MC, Lotze MT, et al. Cytokine regulation of tumour necrosis factor alpha and beta (lymphotoxin) - messenger RNA expression in human peripheral blood mononuclear cells. Cancer Res 1990; 50: 5072-5076.
28. Hart PH, Whitty GA, Piccoli DS, et al. Synergistic activation of human monocytes by granulocyte-machrophage colony-stimulating factor and IFN-γ. Increased TNF-α but not IL-1 activity. J Immunol 1988; 141: 1516-1521.